Standout Papers

The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fou... 2018 2026 2020 2023 305
  1. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States (2018)
    Aaron J. Siegler, Farah Mouhanna et al. Annals of Epidemiology

Immediate Impact

3 from Science/Nature 56 standout
Sub-graph 1 of 19

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
1 intermediate paper

Works of Scott McCallister being referenced

Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults
2016
Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy
2014

Author Peers

Author Last Decade Papers Cites
Scott McCallister 1681 727 414 928 53 2.0k
Katherine Heath 1295 616 470 804 47 1.9k
Moupali Das 1997 881 809 1052 62 2.4k
Michelle E. Roland 2021 774 587 1341 53 2.9k
Zara Shubber 1609 505 263 1068 41 2.0k
C. Bradley Hare 1609 646 295 1166 57 2.3k
Ali Judd 1649 507 289 1592 93 2.8k
Alec Miners 1150 360 258 1218 100 2.6k
Richard Elion 1434 816 423 544 46 1.7k
Joseph Mrus 904 272 315 896 58 2.3k
Caroline Semaille 1356 597 231 1329 82 2.2k

All Works

Loading papers...

Rankless by CCL
2026